# 



## 

## 

## 



## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 




## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

||||Unrestricted|Unrestricted|
|---|---|---|---|---|
|||Note|Funds|Funds|
||||2022|2021|
||||6000|f000|
|Income and endowments|from:||||
|Donations<br>and legacies|||1,034|687|
|Investments|||43|47|
|Other Trading<br>Activities||||6|
|Total income|||1,077|740|
|Expenditure<br>on:|||||
|Raising Funds<br>Charitable<br>Activities|||(136)<br>(353)|(38)<br>(509)|
|Total expenditure|||(489)|(547)|
|Net gains on investments|||125|275|
|Net income|||713|468|
|Other recognised<br>gains/(losses)|||||
|Net movement<br>in funds|||713|468|
|Reconciliation<br>of Funds|||||
|Total funds brought<br>forward|||1,888|1,420|
|Total funds carried forward|||2,601|1,888|





## 

||||||Unrestricted|Unrestricted|
|---|---|---|---|---|---|---|
|||||Note|Funds|Funds|
||||||2022|2021|
||||||6000|6000|
|Fixed assets|||||||
|Investments|||||1,669|1,434|
|Current Assets|||||||
|Debtors||||10|360|10|
|Cash at bank|and|in|hand|1I1|739|508|
||||||1,089|518|
|Creditors: amounts<br>due within one year|||falling|12|(47)|(64)|
|Net Current|Assets||||1,042|454|
|Total assets <br>liabilities|less|current|||2,601|1,888|
|Net assets|||||2,601|1,888|
|Charity Funds|||||||
|Unrestricted|Funds||||2,601|1,888|
|Total charity|funds|||14|2,601|1,888|





## 

## 

|||||Unrestricted|Unrestricted|
|---|---|---|---|---|---|
|||||Funds|Funds|
|||||2022|2021|
|||||f000|5000|
||||Note|||
|Cash flow from operating||activities|13|188|179|
|Cash flow from investing||activities||||
|Dividends|and interest from|investments||43|47|
|Proceeds|from the sale of investments|||1,547|178|
|Purchase|of investments|||(1,547)||
|Net cash|flow from investing<br>activities|||43|225|
|Increase|in cash and cash|equivalents||231|404|
|Cash and <br>beginning|cash equivalents<br>ofthe reporting|at the<br>period||508|104|
|Cash and cash equivalents<br>the reporting<br>period||at the end of||739|508|





## 

## 

## 

## 

## 


## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|||2022|2021|
|---|---|---|---|
|||EOOO|E000|
|Donations|received|678|617|
|Legacies||356|70|
|||1 034|687|



## 

|mounts<br>ex|pended.||||
|---|---|---|---|---|
|Charitable|Activities||2022|2021|
||||EOOO|E000|
|Salaries &|related costs||127|104|
|Audit Fee|(2021-Independent|Examination)|||
|Other|||||
||||133|109|





## 

## 

## 

||||Expenditure|Support Costs|Total|Total|
|---|---|---|---|---|---|---|
||||2022|2022|2022|2021|
||||f000|f000|EOOO|EOOO|
|Unrestricted||Expenditure|||||
|Patient Welfare and Amenities|||71|27|98|122|
|Trust Staff|Welfare &Amenities||103|39|142|103|
|Equipment|(non-capital)||42|15|57|87|
|Equipment||(capital)||||197|
|Building and||Refurbishment|32|12|44||
||||257|96|353|509|



## 

## 

## 



## 

## 

||Moveme|nt<br>in fixe|d as|set in|vestment||||
|---|---|---|---|---|---|---|---|---|
||||||||2022|2021|
||||||||FOOO|E000|
||Market value brought|||forward as at 1 April 2021|||1,434|1,337|
||Add:|Purchases|||||1,647||
||Less:|Sales|||||(1,547)|(178)|
||Add:|Net Gain|on Revaluation||||125|275|
||Market value carried|||forward as at 31 March 2022|||1,559|1 434|
||Market|value offixed||asset|investments||||
||||||||2022|2021|
||||||||EOOO|EOOO|
||COIF|Charities|Investment||tund||1559|1434|
|9|Total gross income from investments|||||and cash on deposit|||
||||||||2022|2021|
||||||||EOOO|EOOO|
||Investment<br>in a||Common||Deposit Fund|(dividends)|43|47|
|10|Debtors||||||||
||||||||2022|2021|
||||||||FOOO|EOOO|
||Other debtors||||||350|10|





## 

|11|Cash at bank|and in h|and|||||
|---|---|---|---|---|---|---|---|
|||||||2022|2021|
|||||||EOOO|EOOO|
||Current Account and Cash Balance<br>COIF Deposit Account|||||636<br>103|448<br>60|
|||||||739|508|
|12|Creditors|||||||
|||||||2022|2021|
|||||||EOOO|FOOO|
||Creditors:|amounts|falling due within|1 year||||
||Accruals|||||47|64|
|13|Reconciliation|of net income to net cash||flow from operating|activities|||



|onciliation<br>of net income to n|et cash flow from operat|ing<br>activities||
|---|---|---|---|
|||2022|2021|
|||EOOO|EOOO|
|Net income for the year||713|468|
|(Gains) on investments<br>Dividends<br>and interest from investments<br>(Increase)<br>in debtors<br>(Decrease)/increase<br>in creditors<br>Net cash flow from operating<br>activities||(125)<br>(43)<br>(340)<br>(17)<br>188|(275)<br>(47)<br>(6)<br>39<br>179|





## 

|14<br>An|al|ysis of|material<br>cha|rita|ble<br>funds|ble<br>funds|2022|2022||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||Fund||Incoming||Resources||Gains||Fund||Fund|
||||Balance|Resources|||Expended|||and|Transfers||Balance|
||||b/fwd||||||(Losses)||||c/fwd|
||||EOOOs|||EOOOs||FOOOs|EOOOs||EOOOs||EOOOs|
|General Fund|||338|||904||(362)||125||3|1,008|
|Cardiac Care||Fund|271|||||(7)|||||264|
|New Cancer|Centre||256|||18|||||||274|
|Health and Wellbeing<br>Hub Fund|||403|||54||(78)|||||379|
|Other Funds|||620|||101||(42)|||(3)||676|
||||1,888|||1,077||(489)||125|||2,601|
|The Trustee <br>designated|set a closing balance greater or equal to E260k as the threshold<br>funds, this was calculated<br>on 10%ofthe total unrestricted<br>funds.||||||||||for reporting||material|
|Analysis ofmaterial<br>charitable||||||funds|2021|||||||
||||Fund||Incoming||Resources||Gains||Fund||Fund|
||||Balance|Resources|||Expended|||and|Transfers||Balance|
||||b/fwd||||||(Losses)||||c/fwd|
||||FOOOs|||EOOOs||EOOOs|EOOOs||EOOOs||EOOOs|
|Unrestricted||Funds||||||||||||
|General Fund|||293|||143||(373)||275|||338|
|Cardiac Care||Fund|323|||13||(65)|||||271|
|Cancer Fund|||222|||1||(6)|||||217|
|New Cancer|Centre||240|||16|||||||256|
|Health and Wellbeing<br>Hub Fund||||||250||(9)|||162||403|
|Other Funds|||342|||317||(94)|||(162)||403|
||||1,420|||740||(547)||275|||1,888|





## 


## 

##